These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1466271)

  • 1. A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
    Okamoto S; Wanaka K; Hijikata-Okunomiya A; Okada Y; Katsuura Y
    Agents Actions Suppl; 1992; 38 ( Pt 1)():198-205. PubMed ID: 1466271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis.
    Wanaka K; Okamoto S; Bohgaki M; Hijikata-Okunomiya A; Naito T; Okada Y
    Thromb Res; 1990 Mar; 57(6):889-95. PubMed ID: 2382257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats.
    Katsuura Y; Okamoto S; Ohno N; Wanaka K
    Thromb Res; 1996 May; 82(4):361-8. PubMed ID: 8743731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of plasma kallikrein inhibitors: functional and structural requirements of plasma kallikrein inhibitors.
    Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):452-7. PubMed ID: 9549887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.
    Fujimori Y; Nakamura T; Shimizu K; Yamamuro T; Wanaka K; Okamoto S; Katsuura Y
    Agents Actions; 1993 May; 39(1-2):42-8. PubMed ID: 8285139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective synthetic inhibitors with regard to plasma-kallikrein activities.
    Okamoto S; Okamoto U; Wanaka K; Hijikata-Okunomiya A; Bohgaki M; Naito T; Horie N; Okada Y
    Adv Exp Med Biol; 1989; 247B():29-34. PubMed ID: 2610076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of trans-4-aminomethylcyclohexanecarbonyl-L- and -D-phenylalanine-4-carboxymethylanilide and examination of their inhibitory activity against plasma kallikrein.
    Wanaka K; Okada Y; Tsuda Y; Okamoto U; Hijikata-Okunomiya A; Okamoto S
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1814-7. PubMed ID: 1394697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A; Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.
    Hashimoto M; Oiwa K; Matsuo O; Ueshima S; Okada K; Okada Y; Okamoto S; Giddings JC; Yamamoto J
    Thromb Haemost; 2003 May; 89(5):820-5. PubMed ID: 12719778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of ONO-3307, a new synthetic protease inhibitor against experimental disseminated intravascular coagulation in rats.
    Yoshikawa T; Takeda S; Naito Y; Kondo M
    Thromb Res; 1990 Oct; 60(1):1-7. PubMed ID: 2278034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of defibrinogenation with batroxobin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kato H; Kondo M
    Thromb Res; 1983 Sep; 31(5):729-35. PubMed ID: 6359574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor.
    Ikarugi H; Inoue A; Yamashita T; Tsuda Y; Okada Y; Ishii H; Yamamoto J
    Thromb Res; 2005; 116(5):403-8. PubMed ID: 16122553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship.
    Teno N; Wanaka K; Okada Y; Taguchi H; Okamoto U; Hijikata-Okunomiya A; Okamoto S
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1079-90. PubMed ID: 8370108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
    Kolte D; Bryant JW; Gibson GW; Wang J; Shariat-Madar Z
    Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):154-66. PubMed ID: 22352684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Kato H; Takemura S; Kondo M
    Haemostasis; 1983; 13(6):374-8. PubMed ID: 6667905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Res Exp Med (Berl); 1981; 179(3):223-8. PubMed ID: 7323452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.